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Abstract
Proper nutrition in palliative care is essential to achieve a good quality of life of patients and better treatment 
results. The diet should include the proper amount of calories and nutrients such as proteins, omega 3 fatty 
acids, dietary fibre, vitamin D and vitamin C. The meals must be balanced, tasty, diverse and appetizing. 
In this paper, an example of one-day diet for adult palliative care patients is proposed.
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Introduction
The main aim of palliative care is to improve the 
quality of life of patients with life-threatening diseases 
[1]. Without doubts, proper nutrition is essential to 
achieve the goals of palliative care. The nutrition-
al needs of palliative care patients differ from the 
healthy population in the following aspects: increased 
metabolism (hypermetabolism), impaired organ func-
tion, increased nutrient losses and malnutrition [2]. 
Moreover, loss of appetite (anorexia), difficulties in 
swallowing, taste alterations are observed in palliative 
care patients [3]. All mentioned alterations result from 
cancer or its treatment, e.g. surgery, chemotherapy 
or radiotherapy.
Nutrition in palliative care
Increased calories intake
Cancer cachexia is strictly related to involuntary 
weight loss. It may be the cause of decreasing the 
quality of life, responsiveness to chemotherapy and 
increased morbidity [4]. Additionally, patients with 
cancer have usually reduced calories intake [5]. There-
fore, to optimize nutrition, in most of palliative care 
patients diet should include more calories than com-
mon diet. Therefore, it is beneficial to add to the 
diet some products rich in calories in a small volume. 
The best high-calorie foods among dairy products 
are butter (735 kcal/100 g), sour cream 18% fat 
(184 kcal/100 g), whipped cream (231 kcal/100 g), 
whole eggs (139 kcal/100 g), cheese (380 kcal/100 g), 
full fat yogurts (117 kcal/100 g) and milk powder 
(478 kcal/100 g). Sweets like chocolate (approximately 
540 kcal/100 g) and honey (324 kcal/100 g) as well 
as nuts (approximately 640 kcal/100 g), seeds (about 
560 kcal/100 g) and peanut butter (695 kcal/100 g) are 
also desired in malnutrition. Some additional products 
such as mayonnaise (714 kcal/100 g), dips, sauces may 
increase the calories intake. Moreover, same fruits, 
vegetables and products made from them can be good 
sources of calories. To this products belong avocado 
(160 kcal/100 g), banana (95 kcal/100 g), dried fruits 
(raisins, dates, figs) (approximately 280 kcal/100 g), 
coconut flesh (283 kcal/100 g). They also include fiber, 
antioxidants and nutrients, therefore they are partic-
ularly beneficial. Fats, both from plants as avocado 
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oil, coconut oil (approximately 880 kcal/100 g) and 
included in fishes or red meat deliver a lot of energy 
in a small volume.
Proteins
Cancer patients often suffer from protein-calorie 
malnutrition, which can lead to the loss of skeletal 
muscle and deterioration in the quality of life [6]. 
Proteins are important to develop and repair body 
tissues and are involved in the production of some 
hormones and enzymes. In palliative patients the 
demand for proteins can be approximately 1.5–2 g 
per kilogram of body mass and two third of them 
should be complete proteins [7]. In comparison, the 
average normal diet should include 0.8 g per kilogram, 
i.e. about 50 g per day. The complete proteins in 
comparison to incomplete proteins contain all eight 
essential amino acids which cannot be produced in 
the human body. Products which are especially rich 
in complete proteins are: meat, fish, eggs and dairy 
products. Plant based sources of complete proteins 
are: soybeans, hempseeds, and quinoa. It is worth 
to increase the amount of protein in the standard 
dishes of palliative care patient’s diet by the addition 
of milk powder to scrambled eggs, sauces, minced 
meat and milk desserts. It is also possible to combine 
incomplete proteins to obtain a full spectrum of es-
sential amino acids. Such combinations include: whole 
grains products with nuts or seeds, whole grains 
products with beans. Also some specialized medical 
nutritional products are available, which are rich in 
calories and proteins. The bottle of 125 ml of such 
product contains approximately 300 kcal and 15–18 g 
of proteins. Moreover, it has been demonstrated that 
supplementation of essential amino acids, especially 
leucine, probably stimulates protein synthesis in hu-
man skeletal muscles, which can be very beneficial in 
palliative care patients suffering from cachexia [8].
Omega 3 fatty acids
Other important nutrients are omega 3 fatty acids, 
which are unsaturated fatty acids with the first double 
bond between the third and fourth carbon atoms 
from the terminal methyl end. Three types of omega 
3 fatty acids extremely important to human nutrition 
are: α-linolenic acid (ALA), eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA). Omega 3 fat-
ty acids are proved to be beneficial in many health 
problems including hypertension [9] and depression 
[10]. Moreover, they can play a role in the reduction 
of inflammation respond. Chronic inflammation sig-
nificantly contributes to the development of cachexia 
in cancer patients [7]. Therefore omega 3 fatty acids 
in palliative care patients’ diet may prevent cachexia. 
It is very important to derive these fatty acids with 
nutrition because of very limited ability to convert 
ALA to EPA and DHA [11]. Moreover, this conversion 
is competitive with omega 6 fatty acids, which appear 
more profusely in the modern human diet [12]. Prod-
ucts which contain ALA include walnut, seeds, algal 
oil, flaxseed oil, and hemp oil. EPA and DHA can be 
found in fish (especially salmon, mackerel, sardine, 
trout), rapeseed oil, soybean oil. Colomer et al. have 
demonstrated in a meta-analysis that supplementa-
tion of about 2 g of EPA and 1 g of DHA can improve 
appetite and prevent weight loss in advanced cancer 
patients. The duration of supplementation differs be-
tween the researchers, but it seems that good results 
can be obtained after 8-week supplementation [13]. 
Taking into consideration that the incidence of side 
effects of such supplementation is very low, it is worth 
considering it in palliative care patients.
Dietary fibre
It is also worth to emphasize the role of dietary 
fibre in the diet which can help to provide the proper 
gut passage and therefore manage with constipation, 
although its role in the management of constipation 
in palliative care patients is limited. Constipation is 
the side effect of repeated administration of opi-
oids, for example, morphine, and concerns a lot of 
patients. Products which are rich in dietary fibre are 
vegetables, fruits, whole grains products. Avocado is 
a fruit that is particularly beneficial in the palliative 
care patient diet. It is rich in dietary fiber (6.8 g per 
100 g) [14]. Moreover, it contains a great number of 
calories in comparison to other fruits, which can help 
to avoid weight loss. A standard portion of avocado 
is one half of the fruit (about 70 g) every day.
Vitamin D
The proper intake of vitamins is also vital in palli-
ative care patients’ diet. Vitamin D is not only crucial 
for proper formation and mineral homeostasis of 
bones [15], but it is also vital for the proper immune 
and nervous systems function [16,17]. It was demon-
strated that cancer patients more often suffer from 
vitamin D deficiency (< 50 nmol/L) [18]. Moreover, 
cancer patients with a lower vitamin D level experi-
enced more intense pain and in consequence, needed 
higher opioids doses [19]. Supplementation of vitamin 
D in cancer patients improves pain management and 
reduces susceptibility to infections [20], which results 
in fewer opioids and antibiotics usage and a smaller 
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number of their side effects. There is evidence that 
vitamin D can be also beneficial in depressive disor-
ders [21], which may be helpful in palliative care as 
symptoms of depression are very common in cancer 
patients. The main source of vitamin D in the body is 
the endogenous synthesis in the skin, which requires 
the presence of sunlight. A small amount of vitamin 
D is delivered through diet. Products which contain 
vitamin D are fish, meat, and plants [22]. Oral supple-
mentation of this vitamin is very popular and advisable 
as it is well–tolerated and safe. The recommended 
dose of vitamin D supplementations for cancer pa-
tients is 4000 IU/day [20].
Vitamin C
Another vitamin that seems to be vital in palliative 
care patients diet is vitamin C (ascorbate). Vitamin C 
plays a crucial role in the human body. It is the antiox-
idant and the cofactor of several important enzymes 
[23, 24]. Humans cannot synthesize vitamin C, so it 
is crucial to delivering it through the diet. Palliative 
care patients very often face with vitamin C deficiency 
(plasma vitamin C concentrations < 11 µmol/L) [25] 
especially because it has been demonstrated that pa-
tients under oxidative stress, for example in surgical 
intensive care, have greater requirements for vitamin 
C [26]. The administration of anti-cancer drugs may in-
duce a decrease in patients’ vitamin C concentrations 
[27–29]. Although the effect of vitamin C on cancer 
treatment is controversial, it has been demonstrated 
that high doses of this vitamin can reduce pain, which 
is the biggest issue to deal with in palliative care pa-
tients. In a retrospective study of 39 advanced cancer 
patients, Günes-Bayir and Kiziltan have demonstrated 
that there was a median reduction of 50% in pain 
among the patients who obtained an infusion of 
2.5 g ascorbic acid [30]. Moreover, in the prospective 
study of 39 advanced cancer patients administration 
of vitamin C (10 g vitamin C intravenously twice with 
a 3-day interval and an oral intake of 4 g vitamin C dai-
ly for a week) improved the quality of life reported as 
better physical, emotional and cognitive functioning 
as well as less intensity of symptoms such as fatigue, 
nausea, vomiting, pain, and appetite loss [31]. In the 
retrospective multicenter cohort study of 125 women 
diagnosed with breast cancer patients were divided 
into two groups: the group of 53 patients who were 
treated with 7.5 g of vitamin C for 4 weeks in addition 
to standard anti-cancer therapy and control group of 
72 women who obtained only standard anti-cancer 
therapy. The first group reported less chemotherapy 
and radiotherapy side effects (nausea, loss of appetite, 
depression, sleep disorders) [32]. Moreover, there 
are studies reporting a substantial decrease in opioid 
requirements in advanced cancer patients [33, 34].
One day-diet
Please find below an example of a balanced 
one day-diet for palliative care patients. It contains 
2900 kcal, 120 g of proteins, 99 g of fat, 370 g of 
carbohydrates and 45 g of fibre.
First breakfast
Scrambled eggs, sandwiches, fruit juice:
• 2 eggs (120 g)
• 2 slices of whole grain bread (80 g)
• 2 spoons of butter (10 g)
• 2 slices of ham poultry (30 g)
• glass of fresh fruit juice (250 mL)
Second breakfast
Milk cocktail:
• a glass of natural yoghurt (150 g)
• 1 standard banana (130 g)
• strawberries/raspberries (150 g)
• small spoon of honey (12 g)
• a spoon of milk powder (15 g)
• 1/2 of a small onion (60 g)
• 1/2 glass of tomato puree (50 g)
• 2–3 spoons of cream (40 g)
Lunch
Meat balls in tomato sauce, avocado salad:
• minced poultry meat – 150 g
• 1/3 of egg
• one spoon of semolina (10 g)
• 1/2 glass of barley (80 g of dry product)
• 1/2 of a medium avocado
• 1 medium tomato
Snack
Yeast dough and fruit:
• yeast dough — 120 g
• 1 standard orange (200 g)
Supper
Sandwiches, cottage cheese with vegetables and seeds:
• 2 slices of whole grain bread (80 g)
• 2 spoons of butter (10 g)
• 2 slices of ham poultry (30 g)
• 1/2 glass of cottage cheese (80 g)
• a few radishes (50 g)
• a few slices of cucumber (50 g)
• 2 spoons of pumpkin seeds (15 g).
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Summary
To sum up, in palliative care patients it is important 
to emphasize the right amount of calories and mac-
ronutrients as it can improve the patient’s nutritional 
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